Considerations on safety and treatment of patients with chronic heart failure at high altitude

Research output: Contribution to journalArticlepeer-review

Abstract

Piergiuseppe Agostoni. Considerations on safety and treatment of patients with chronic heart failure at high altitude. High Alt Med Biol 14:96-100, 2013. - Prognosis and quality of life of chronic heart failure (HF) patients have greatly improved over the last decade. Consequently, many patients are willing to spend leisure time at altitude, usually 1-β2-α- blocker, reduces the hypoxic ventilatory response through a reduction of the chemoreflex response, and it reduces alveolar-capillary gas diffusion, which is under control by β2-receptors. These actions are not shared by selective β1-blockers such as bisoprolol and nebivolol, which should be preferred for treatment of HF patients willing to spend time at altitude. In conclusion, spending time at altitude (

Original languageEnglish
Pages (from-to)96-100
Number of pages5
JournalHigh Altitude Medicine and Biology
Volume14
Issue number2
DOIs
Publication statusPublished - Jun 1 2013

ASJC Scopus subject areas

  • Medicine(all)
  • Physiology
  • Public Health, Environmental and Occupational Health

Fingerprint Dive into the research topics of 'Considerations on safety and treatment of patients with chronic heart failure at high altitude'. Together they form a unique fingerprint.

Cite this